Standout Papers

GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, sin... 2023 2026 202489
  1. GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial (2023)
    Mingming Zhang, Guoqing Wei et al. The Lancet Haematology

Immediate Impact

50 standout
Sub-graph 1 of 18

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
3 intermediate papers

Works of Jiazhen Cui being referenced

GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
2023 Standout
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti‐Leukemia Efficacy of CAR‐T Cells via SOCE‐Calcineurin‐NFAT and Glycolysis Pathways
2022
and 1 more

Author Peers

Author Last Decade Papers Cites
Jiazhen Cui 282 129 71 108 36 373
Liora M. Schultz 328 125 44 195 35 427
Jörg Faber 190 141 107 104 30 454
Yaohui Wu 252 116 93 60 25 362
Adolfo Aleman 222 204 128 56 33 412
Chunrong Tong 319 106 100 107 50 429
Xinjie Xu 277 152 91 95 35 456
Rawan Faramand 197 147 111 56 37 355
Haodong Cai 172 153 92 65 27 397
Cuicui Lyu 228 154 69 92 35 413
Vincent Allain 210 161 25 77 22 341

All Works

Loading papers...

Rankless by CCL
2026